PHOENIX, Ariz. — August 22, 2022 — Nonalcoholic fatty liver disease (NAFLD) is both increasingly common and potentially deadly; yet its causes remain poorly understood. Now, a collaborative team of researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, and Temple University has uncovered a link between decreases in an enzyme that makes choline in the liver —an essential nutrient for humans— and severity of NAFLD.
Up to $50,000 in seed investments is available for faculty who recently started a company to commercialize Arizona State University-owned inventions during the fourth annual Skysong Innovations Startup Challenge.
- Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen
- The Fourth Executive Order, relating to “Most Favored Nations” pricing for Medicare Part B treatments is set to take effect on August 24, 2020 unless industry and the administration agree to an alternate plan.
This week AZBio will be in Washington, D.C. meeting with our Arizona Congressional Delegation and thanking them for their work and support in permanently repealing the Medical Device Excise Tax. AZBio will be joining medtech leaders from across the country as part of the annual AdvaMed Fly-In. Even if you are not able to be with us LIVE in Washington, D.C. you can share your thanks with your Representative and Senators electronically by clicking here. Continue reading
On September 24, 2019, a letter was sent to Congressional Leaders in the Senate and House leadership on behalf of a group of over six hundred innovators, patient groups, physicians, hospitals, venture capitalists and other stakeholders representing millions of patients and hundreds of thousands medical technology jobs, requesting that Congress prioritize repeal of the medical device excise tax before it causes any more harm to the innovation ecosystem. Continue reading
The 2017 AZBio Trailblazer Honorees are: House Speaker JD Mesnard, Senator Nancy Barto, Senator Kimberly Yee, Senator Kate Brophy McGee, Representative Lela Alston, Representative Heather Carter, Representative Regina Cobb, DDS, Representative Randall Friese, MD, and Representative Jay Lawrence.Continue reading
Washington, D.C. (April 5, 2017) – The Biotechnology Innovation Organization (BIO) announced today its selection of Congresswoman Kyrsten Sinema (D-AZ) as a 2017 Legislator of the Year. Congresswoman Sinema will receive the award in conjunction with BIO’s Legislative Day Fly-In.
AZBio delivered data on life-changing innovation and the economic impact of Arizona’s life sciences industry to Arizona’s Congressional Delegation last week in meetings with 10 of Arizona’s 11 Congressional offices.